Fundraising Fox

Kilele Health

Oakwood, US · Founded 2023 · Delaware corporation · 1 known investors

kilelehealth.com

Kilele Health develops the SunVida platform, a continuous biochemical monitoring system built on aptamer sensor technology in a glucose-monitor-style device format that provides real-time and longitudinal molecular data such as phenylalanine levels. It targets chronic disease management use cases including PKU, GLP-1 therapy muscle-loss monitoring, diabetes, chronic kidney disease, and heart failure for patients and clinical care teams.

BiotechDeep TechDigital HealthMedical Devices

Founders & leadership

SS
Sven SchreiberExecutive
BN
Brittany Nicole ArdeExecutive
JC
Jason Charles HeikenfeldNamed on SEC filing
AD
Andrew David CothrelNamed on SEC filing

Investors · 1

Competitors · 3

by search overlap

Companies competing with Kilele Health for the same Google search keywords, organic and paid, via search-intersection analysis.

Reported raises · per SEC filings

Form D private placements

$264.5K disclosed across 1 round · 2025

$264.5KraisedOct 2025 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jason Charles HeikenfeldExecutive Officer, Director, Promoter
  • Sven SchreiberExecutive Officer
  • Andrew David CothrelExecutive Officer, Director, Promoter
  • Brittany Nicole ArdeExecutive Officer
Offering amount
$2M
Amount sold
$264.5K
Minimum investment
$48K
First sale
Sep 2025
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Science FoundationPhase ISTTR2022$255.9K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Kilele Health do?
Kilele Health develops the SunVida platform, a continuous biochemical monitoring system built on aptamer sensor technology in a glucose-monitor-style device format that provides real-time and longitudinal molecular data such as phenylalanine levels. It targets chronic disease management use cases including PKU, GLP-1 therapy muscle-loss monitoring, diabetes, chronic kidney disease, and heart failure for patients and clinical care teams.
Who are Kilele Health's investors?
Kilele Health's investors include JumpStart Equity.
How much funding has Kilele Health raised?
Kilele Health has disclosed $264.5K raised across 1 round.
Where is Kilele Health headquartered?
Kilele Health is headquartered in Oakwood, US.